gvs 111 has been researched along with Anxiety in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gol'dzon, MA; Khlebova, NV; Kondria, AV; Lysov, AV; Mordyk, AV | 1 |
| Iarkova, MA | 1 |
2 other study(ies) available for gvs 111 and Anxiety
| Article | Year |
|---|---|
[Prevention of neuro- and cardiotoxic side effects of tuberculosis chemotherapy with noopept].
Topics: Adolescent; Adult; Antitubercular Agents; Anxiety; Dipeptides; Follow-Up Studies; Humans; Middle Aged; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
[Analysis of the binding capacity of the benzodiazepine site of gabaa receptor in mice C57BL/6 and BALB/C pretreated with anxiolytics].
Topics: Adamantane; Animals; Anti-Anxiety Agents; Anxiety; Benzimidazoles; Benzodiazepines; Brain; Cats; Dipeptides; Flunitrazepam; GABA-A Receptor Agonists; Male; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholines; Receptors, GABA-A; Species Specificity; Stress, Physiological; Synaptosomes; Tritium | 2011 |